PE20140996A1 - Comprimido masticable de ibuprofeno - Google Patents

Comprimido masticable de ibuprofeno

Info

Publication number
PE20140996A1
PE20140996A1 PE2013002908A PE2013002908A PE20140996A1 PE 20140996 A1 PE20140996 A1 PE 20140996A1 PE 2013002908 A PE2013002908 A PE 2013002908A PE 2013002908 A PE2013002908 A PE 2013002908A PE 20140996 A1 PE20140996 A1 PE 20140996A1
Authority
PE
Peru
Prior art keywords
chewable tablet
ibuprofen
ibuprofen chewable
antipiretic
sweetener
Prior art date
Application number
PE2013002908A
Other languages
English (en)
Inventor
John Jiangnan Liu
Lei Yang
Fang Yang
Original Assignee
Sino American Tianjin Smithkline And French Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45005458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140996(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sino American Tianjin Smithkline And French Lab Ltd filed Critical Sino American Tianjin Smithkline And French Lab Ltd
Publication of PE20140996A1 publication Critical patent/PE20140996A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UN COMPRIMIDO MASTICABLE DE SABOR ENMASCARADO Y COMPRIMIDO DIRECTAMENTE QUE COMPRENDE: A) IBUPROFENO EN UNA CANTIDAD DE 200 A 400 MG CUYO TAMANO MEDIO DE PARTICULA ES DE 250 A 400 uM; Y B) UN VEHICULO FARMACEUTICAMENTE ACEPTABLE TAL COMO DILUYENTE, AGLUTINANTE, EDULCORANTE, LUBRICANTE, ENTRE OTROS. DICHA COMPOSICION ES UTIL COMO ANALGESICO Y ANTIPIRETICO
PE2013002908A 2011-07-01 2012-06-18 Comprimido masticable de ibuprofeno PE20140996A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110182886A CN102258490B (zh) 2011-07-01 2011-07-01 布洛芬咀嚼片

Publications (1)

Publication Number Publication Date
PE20140996A1 true PE20140996A1 (es) 2014-09-11

Family

ID=45005458

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002908A PE20140996A1 (es) 2011-07-01 2012-06-18 Comprimido masticable de ibuprofeno

Country Status (10)

Country Link
US (1) US20140134245A1 (es)
EP (1) EP2726063A4 (es)
CN (1) CN102258490B (es)
AP (1) AP3309A (es)
AR (1) AR086789A1 (es)
CO (1) CO6900137A2 (es)
PE (1) PE20140996A1 (es)
RU (1) RU2567050C2 (es)
TW (1) TW201315462A (es)
WO (1) WO2013004123A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104000791A (zh) * 2014-06-10 2014-08-27 安徽省逸欣铭医药科技有限公司 一种柠檬酸铁咀嚼片
CN104434832A (zh) * 2014-12-05 2015-03-25 海南卫康制药(潜山)有限公司 一种布洛芬组合物咀嚼片及其制备方法
SI3377044T1 (sl) * 2015-11-18 2021-12-31 Hermes Pharma Gmbh Ibuprofenski sestavki za neposredno oralno dajanje
EP3860599B1 (en) 2018-10-04 2024-05-15 Adeptio Pharmaceuticals Limited (+)-alpha-dihydrotetrabenazine dosage regimen for treating movement disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1078140A (zh) * 1992-04-27 1993-11-10 陈晓华 高生物利用度布洛芬片的制备方法
TW442287B (en) * 1995-06-13 2001-06-23 American Home Produits Corp Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac)
NZ333474A (en) * 1998-01-02 1999-06-29 Mcneil Ppc Inc A chewable tablet containing ibuprofen, fumaric acid and a non hydrocolloid binder e.g. a wax or a fat
US6099865A (en) * 1998-07-08 2000-08-08 Fmc Corporation Croscarmellose taste masking
US20020122823A1 (en) * 2000-12-29 2002-09-05 Bunick Frank J. Soft tablet containing dextrose monohydrate
AU2006312119B2 (en) * 2005-11-02 2010-04-29 Teikoku Pharma Usa, Inc. Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
BRPI0718428A2 (pt) * 2006-10-25 2013-11-12 Mcneil Ppc Inc Composição de ibuprofeno
CN101390844B (zh) * 2007-09-23 2011-11-09 天津医科大学 精氨酸布洛芬片剂及其制备方法
CN101978955A (zh) * 2010-11-05 2011-02-23 航天中心医院 右旋布洛芬氨基酸盐片剂及其制备方法

Also Published As

Publication number Publication date
EP2726063A4 (en) 2015-02-25
AR086789A1 (es) 2014-01-22
US20140134245A1 (en) 2014-05-15
TW201315462A (zh) 2013-04-16
RU2014103479A (ru) 2015-08-10
CN102258490B (zh) 2012-10-03
EP2726063A1 (en) 2014-05-07
AP2013007326A0 (en) 2013-12-31
WO2013004123A1 (en) 2013-01-10
CN102258490A (zh) 2011-11-30
RU2567050C2 (ru) 2015-10-27
AP3309A (en) 2015-06-30
CO6900137A2 (es) 2014-03-20

Similar Documents

Publication Publication Date Title
AR124140A2 (es) Formulaciones de anticuerpos
AR115939A2 (es) Composición que contiene palmitoil-etanolamida ultra-micronizada
CO6531427A2 (es) Composiciones de corticosteriodes administradas oralmente
AR087359A1 (es) Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco
MX2009011588A (es) Formas de dosificacion solidas que comprenden tadalafil.
WO2009063222A3 (en) Solid compositions
CO6400186A2 (es) Tabletas de acetato de ulipristal
PE20090165A1 (es) Composicion farmaceutica a base de telmisartan
CR20110367A (es) Particulas en polvo recubiertas
PE20140996A1 (es) Comprimido masticable de ibuprofeno
GT201500035A (es) Composición farmacéutica oral en forma de microesferas y proceso de elaboración
MX2009012523A (es) Composiciones utiles para reducir la nefrotoxicidad y metodos para utilizarlas.
MX348933B (es) Composiciones, formas de dosificacion y coadministracion de un compuesto agonista opioide y un compuesto analgesico.
WO2015056094A3 (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent
PH12014501408A1 (en) Immediate release multi unit pellet system
EA201291211A1 (ru) Фармацевтические композиции, содержащие гидроморфон и налоксон
EA201171497A1 (ru) Снижение флуктуаций опиоидов в крови
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
CL2013003700A1 (es) Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico.
PE20110943A1 (es) Formulacion oral solida de alisquireno
RU2016133305A (ru) Состав с длительным высвобождением для снижения частоты мочеиспускания и способ его применения
MX366533B (es) Gel oral para sensibilidad y dolor dental.
JO3112B1 (ar) تركيبة دوائية سريعة التحلل
AR082215A1 (es) Composicion farmaceutica agradable al paladar
MX363389B (es) Composicion farmaceutica que comprende ivabradina amorfa.

Legal Events

Date Code Title Description
FD Application declared void or lapsed